Abstract
A critical appraisal and clinical application of Janion-Sadowska A, Papuga-Szela E, Łukaszuk R, et al. Non–Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Thrombocytopenia. Journal of Cardiovascular Pharmacology. 2018;72(3):153-160. doi: 10.1097/fjc.0000000000000607
DOI
10.22237/crp/1567555920
Recommended Citation
GROSS M. Reduced doses of direct oral anticoagulation are safe in atrial fibrillation patients with mild thrombocytopenia. Clin. Res. Prac. 2019 Sep 18;5(2):eP1995. doi: 10.22237/crp/1567555920
COinS
